SUNSHINE PHARMA (06887): Zhang Zhiyong selected as employee director.
Dongyang Guangyao (06887) announced that Mr. Zhang Zhiyong was elected as an employee director (executive director) of the second board of directors after being selected by the company's employees' representative assembly on June 18, 2026. His term of office shall commence on the date of approval by the annual general meeting of shareholders of the second board of directors (i.e. June 18, 2026) and shall expire upon the completion of the term of office of the second board of directors.
SUNSHINE PHARMA (06887) announced that on June 18, 2026, Mr. Zhang Zhiyong was elected as an employee director (executive director) of the second board of directors after being selected by the company's employee representative assembly. His term will start on the day of approval by the annual general meeting of shareholders of the second board of directors (i.e. June 18, 2026) and will last until the expiration of the term of the second board of directors.
Related Articles
.png)
US Stock Market Move | "The 'American Retail Investors Headquarters' Robinhood (HOOD.US) rose nearly 4%, with a cumulative increase of 56% since April."
Challenge NVIDIA Corporation's dominance! Amazon.com, Inc. (AMZN.US) plans to sell self-developed AI chips to external data centers, causing the stock price to rise by over 2%.
A-share evening hotspots | Eight departments deploy! AI+ consumption welcomes heavy positive news, institutions sort out beneficiary directions.
US Stock Market Move | "The 'American Retail Investors Headquarters' Robinhood (HOOD.US) rose nearly 4%, with a cumulative increase of 56% since April."
Challenge NVIDIA Corporation's dominance! Amazon.com, Inc. (AMZN.US) plans to sell self-developed AI chips to external data centers, causing the stock price to rise by over 2%.
A-share evening hotspots | Eight departments deploy! AI+ consumption welcomes heavy positive news, institutions sort out beneficiary directions.
RECOMMEND
